CEO
Regatta Medical
Bannockburn, Illinois, United States
Chip Hance is a Board Member for the Medical Device Innovation Consortium and is the Board Champion for the Early Feasibility Clinical Trial Initiative.
He has spent more than 30 years in the medical device industry, most recently as CEO of Regatta Medical, and before that, CEO of Creganna Medical, leading component makers of minimally invasive medical devices.
In 2012-13, Hance was an Entrepreneur-in-Residence at CDRH within the FDA. He co-led the Innovation Pathway team focused on streamlining aspects of medical device clinical trials in the U.S.
Prior to his FDA experience, Hance was most recently President of Abbott Vascular, the cardiovascular device division of Abbott.
Hance earned a bachelor's degree in Chemical Engineering from the Massachusetts Institute of Technology and a master's degree in Business Administration from Harvard Business School.